Neil Brewis

Insider Reports History

Location
Cambridge, United Kingdom
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Neil Brewis:

Company Role Class Num Shares Value Price $ Report Date Ownership
F-star Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 0 $7.12 08 Mar 2023 Direct
F-star Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (right to buy) 0 08 Mar 2023 Direct

Insider Reports Filed by Neil Brewis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924323007662-brewis-neil-2023-03-08 F-star Therapeutics, Inc. 08 Mar 2023 5 -$814,977 4 CHIEF SCIENTIFIC OFFICER 09 Mar 2023, 08:16
/report/000120919122044006-brewis-neil-2022-07-29 F-star Therapeutics, Inc. 29 Jul 2022 3 +$8,428 4 Chief Scientific Officer 02 Aug 2022, 21:07
/report/000120919122022298-brewis-neil-2022-03-31 F-star Therapeutics, Inc. 31 Mar 2022 1 $0 4 Chief Scientific Officer 04 Apr 2022, 16:02
/report/000120919122002919-brewis-neil-2022-01-09 F-star Therapeutics, Inc. 09 Jan 2022 1 $0 4 Chief Scientific Officer 11 Jan 2022, 16:30